Text Size: A- A+ Facebook Twitter LinkedIn YouTube

Breaking News

Pledge the Gift of Life

Each year, the lives of thousands of people across the country are saved because someone made the choice to become an organ donor. In April, Allegheny Health Network is honored to celebrate National Donate Life Month and pay tribute to all of those who have bestowed the precious gift of life to another through organ donation. Visit AHNdonate.org to learn more and register to be an organ donor.



Format: 04/17/2014
Format: 04/17/2014


Scripps News: Neurosurgeons hope compound extends lives

Thursday, February 25th, 2010

John Rotella began "losing names and what was going on."
Donald Marsh began having "dizzy spells and lightheadedness."
Different symptoms but the same diagnosis: They each had a glioma, the most common form of a brain tumor. High-grade gliomas like theirs are rapidly progressive and often fatal.
The two also ended up having the same treatment at Pittsburgh's Allegheny General Hospital. There, with federal approval, neurosurgeons are studying a drug compound that makes it easier to cut out more of the tumor during open brain surgery, extending life expectancy.
Rotella's and Marsh's surgeries were among the first 12 procedures done at Allegheny General since it got the OK from the Food and Drug Administration to do 50 of them.
The study is one of four early-stage trials around the nation to evaluate the safety and effectiveness of the compound 5-aminolevulinic acid, referred to as ALA.
Taken orally three hours before open brain surgery, ALA turns into a fluorescent substance when it enters cancerous tumor cells. When seen under a special blue light, the tumor then appears red amid the white color of the brain. That makes it easier for neurosurgeons to see -- and remove -- more of the tumor.
"Before, we would have left more stuff behind," said Dr. Matthew Quigley, director of the division of neurosurgical oncology at Allegheny General, the primary investigator of the study and one of the neurosurgeons doing the procedures. The surgeons and the two patients spoke Thursday in a news conference on the study's progress.
"The tumor is notoriously difficult to remove," Quigley added. "Things that look normal are very infiltrated with malignant cells."

To read the rest of the story, please visit this link to Scripps News.

West Penn Allegheny Health System
Tell us who you are:

What areas do you use on our website?*
(select more than one if it applies)

Did you find what you were looking for?

Would you refer others to our website?

Can we contact you for future questions?

CAPTCHA math question:* 3 + 7 =

Thank you for completing the West Penn Allegheny Health System website survey.
We value your feedback and comments.